Paula Treutiger
Investor Relations Contact bei SENZIME AB
Profil
Paula Treutiger is currently the Head of Communication & Investor Relations at Senzime AB since 2022.
Prior to this, she worked as the Director at CellaVision AB, Director of Corporate Communication & IR at Medicover AB, Portfolio Manager at Swedbank Robur Fonder AB, Vice President of Corporate Communications at Gambro AB, and Head of Communications, IR & Sustainability Media at Meda AB from 2011 to 2014.
She also worked as an Analyst at ABN AMRO SE in 2005.
Ms. Treutiger completed her undergraduate degree at the University of Stockholm.
Aktive Positionen von Paula Treutiger
| Unternehmen | Position | Beginn |
|---|---|---|
| SENZIME AB | Investor Relations Contact | 01.10.2022 |
Ehemalige bekannte Positionen von Paula Treutiger
| Unternehmen | Position | Ende |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | - |
Swedbank Robur Fonder AB
 Swedbank Robur Fonder AB Investment ManagersFinance Swedbank Robur Fonder AB (Swedbank Robur) is the wholly-owned fund management subsidiary of Swedbank Robur AB, itself a subsidiary of Swedbank AB (STO: SWED.A, ADR: SWDBY) in Sweden. Founded in 1967, the firm is headquartered in Stockholm and manages a range of equity and fixed-income funds for private individuals and institutions including unions, primarily in Sweden. They also provide discretionary account management for institutional clients. Swedbank Robur is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI). | Portfolio Manager-Equities | 02.06.2011 |
| ABN AMRO SE | Analyst-Equity | 11.03.2005 |
| MEDICOVER AB | Investor Relations Contact | - |
| MEDA AB | Investor Relations Contact | - |
Ausbildung von Paula Treutiger
| University of Stockholm | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SENZIME AB | Health Technology |
| CELLAVISION AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| MEDICOVER AB | Health Services |
| Private Unternehmen | 4 |
|---|---|
Swedbank Robur Fonder AB
Swedbank Robur Fonder AB Investment ManagersFinance Swedbank Robur Fonder AB (Swedbank Robur) is the wholly-owned fund management subsidiary of Swedbank Robur AB, itself a subsidiary of Swedbank AB (STO: SWED.A, ADR: SWDBY) in Sweden. Founded in 1967, the firm is headquartered in Stockholm and manages a range of equity and fixed-income funds for private individuals and institutions including unions, primarily in Sweden. They also provide discretionary account management for institutional clients. Swedbank Robur is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI). | Finance |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
Meda AB
 Meda AB Pharmaceuticals: MajorHealth Technology Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden. | Health Technology |
| ABN AMRO SE | Finance |
